Effects of amiodarone-induced phospholipidosis on pulmonary host defense functions in rats

Proceedings of the Society for Experimental Biology and Medicine

Volumn 211, Issue 4, 1996, Pages 346-352

  Reasor, Mark J ^a   McCloud, Christy M ^a   DiMatteo, Michael ^a   Schafer, Rosana ^a   Ima, Azine ^b   Lemaire, Irma ^b  

^a WEST VIRGINIA UNIVERSITY   (United States)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; HOST RESISTANCE; INFECTION RISK; LIPIDOSIS; LUNG ALVEOLUS MACROPHAGE; LUNG CLEARANCE; LUNG DISEASE; MALE; NONHUMAN; PHAGOCYTOSIS; RAT;

ANIMALIA; LISTERIA MONOCYTOGENES;

EID: 0029936478     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: 10.3181/00379727-211-43979     Document Type: Article

References (38)

1. Reasor MJ, Kacew S. Amiodarone pulmonary toxicity: Morphologic and biochemical features. Proc Soc Exp Biol Med 196:1-7, 1990.
2. Mason JW. Medical intelligence: Drug therapy, amiodarone. N Engl J Med 316:455-466, 1987.
3. Reasor MJ. Role of the alveolar macrophage in the induction of pulmonary phospholipidosis: Pharmacologic and toxicologic considerations. In: Hollinger MA, Ed. Current Topics in Pulmonary Pharmacology and Toxicology. New York: Elsevier Science, pp 43-71, 1987.
4. Lehnert BE, Ferin J. Particle binding, phagocytosis, and plastic substrate adherence characteristics of alveolar macrophages from rats treated acutely with chlorphentermine. J Reticuloendothel Soc 33:293-303, 1983.
5. Ferin J. Alveolar macrophage mediated pulmonary clearance suppressed by drug-induced phospholipidosis. Exp Lung Res 4:1-10, 1982.
6. Wilson BD, Clarkson CE, Lippmann ML. Amiodarone causes decreased cell-mediated immune responses and inhibits the phospholipase C signaling pathway. Lung 170:137-148, 1993.
7. McNulty MJ, Reasor MJ. Enhanced phagocytic and bactericidal activities of phospholipidotic rat alveolar macrophages. J Reticuloendothel Soc 30:534-549, 1981.
8. McNulty MJ, Reasor MJ. Iprindole-induced phospholipidosis in rat alveolar macrophages: Alterations in oxygen consumption and release of oxidants. Exp Lung Res 2:57-69, 1981.
9. Reasor MJ, Koshut RA, McNulty MJ, Trush MA. Chemiluminescence of rat alveolar macrophages following induction of phospholipidosis with chlorphentermine. Toxicol Appl Pharmacol 52:497-506, 1980.
10. Wilson BD, Lippmann ML. Amiodarone pulmonary toxicity in the rat is associated with increased lavage immunoglobulin and alveolar macrophages primed for increased interleukin-1 secretion. Am J Respir Cell Mol Biol 9:295-299, 1993.
11. Waites CR, Bugelski PJ, Badger AM. Biochemical and functional analysis of rat bronchoalveolar macrophages containing chemically induced phospholipid inclusions. Toxicol Appl Pharmacol 130:316-320, 1995.
12. Sibille Y, Reynolds HY. Macrophages and polymorphonuclear neutrophils in lung defense and injury. Am Rev Respir Dis 141:471-501, 1990.
13. Brain JD. Toxicological aspects of alterations of pulmonary macrophage function. Ann Rev Pharmacol Toxicol 26:547-565, 1986.
14. Sherman MP, Ganz T. Host defense in pulmonary alveoli. Annu Rev Physiol 54:331-350, 1992.
15. Pison U, Max M, Neuendank A, Weissbach S, Pietschmann S. Host defence capacities of pulmonary surfactant: Evidence for 'non-surfactant' functions of the surfactant system. Eur J Clin Invest 24:586-599, 1994.
16. Reasor MJ, Ogle CL, Walker ER, Kacew S. Amiodarone-induced phospholipidosis in rat alveolar macrophages. Am Rev Respir Dis 137:510-518, 1988.
17. Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissue. J Biol Chem 226:497-509, 1957.
18. Ames BN, Dubin DT. The role of polyamines in the neutralization of bacteriophage deoxyribonucleic acid. J Biol Chem 235:769-775, 1960.
19. Antonini JM, Van Dyke K, Ye Z, DiMatteo M, Reasor MJ. Introduction of luminol-dependent chemiluminescence as a method to study silica inflammation in tissue and phagocytic cells of rat lung. Environ Health Perspect 102:(Suppl 10):37-42, 1994.
20. Lemaire I. Bombesin-related peptides modulate interleukin-1 production by alveolar macrophages. Neuropeptides 20:217-223, 1991.
21. Lemaire I, Yang H, Cantin M-F, Lemaire S. Upregulation of cytokine production in alveolar macrophages by histogranin, a novel endogenous pentadecapeptide. Immunol Lett 41:37-42, 1994.
22. Pizarro TT, Malinowska K, Kovacs EJ, Clancy J Jr., Robinson JA, Piccinini LA. Induction of TNF-alpha and TNF-beta gene expression in rat. Transplant 56:399-404, 1993.
23. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: Physiology, pathophysiology and pharmacology. Pharmacol Rev 43:109-142, 1991.
24. Croen KD. Evidence for antiviral effects of nitric oxide: Inhibition of herpes simplex virus type 1 replication. J Clin Invest 91:2446-2452, 1993.
25. Pendino KJ, Laskin JD, Sheuler RI, Punjabe CJ, Laskin DL. Enhanced production of nitric oxide by rat alveolar macrophages after inhalation of a pulmonary irritant is associated with increased expression of nitric oxide synthase. J Immunol 151:7196-7205, 1993.
26. Akira S, Hirano T, Taga T, Kishimoto T. Biology of multifunctional cytokines: IL-6 and related molecules (IL-1 and TNF). FASEB J 4:2860-2867, 1990.
27. Hirano T, Akira S, Taga T, Kishimoto T. Biological and clinical aspects of interleukin 6. Immunol Today 11:443-449, 1990.
28. Clark SC. Interleukin-6: Multiple activities in regulation of the hematopoietic and immune systems. Ann N Y Acad Sci 557:438-443, 1989.
29. Sauty A, Mauel J, Philippeaux M-M, Leuenberger P. Cytostatic activity of alveolar macrophages from smokers and nonsmokers: Role of interleukin-1 beta, interleukin-6, and tumor necrosis factor-alpha. Am J Respir Cell Mol Biol 11:631-637, 1994.
30. Van Snick J. Interleukin-6: An overview. Annu Rev Immunol 18:253-278, 1990.
31. Pfeffer K, Matsuyama T, Kundig TM, Wakeham A, Kishihara K, Shahinian A, Wiegmann K, Ohashi PS, Kronke M, Mak TW. Mice deficient for the 55kDa tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 73:457-467, 1993.
32. Rothe J, Lesslauer W, Lotscher H, Lang Y, Koebel P, Kontgen F, Althuge A, Zinkernagel R, Steinmetz M, Bluethmann H. Mice lacking the tumor necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 364:798-802, 1993.
33. Kelley J. Cytokines of the lung. Am Rev Respir Dis 141:765-788, 1990.
34. Driscoll KE, Maurer JK. Cytokine and growth factor release by alveolar macrophages: Potential biomarkers of pulmonary toxicity. Toxicol Pathol 19:398-405, 1991.
35. Wilson BD, Jaworski AJ, Donner ME, Lippmann ML. Amiodarone-induced pulmonary toxicity in the rat. Lung 167:301-311, 1989.
36. Hahn H, Kaufmann SHE. The role of cell-mediated immunity in bacterial infections. Rev Infect Dis 3:1221-1250, 1981.
37. Harding CV, Geuze HJ. Class II MHC molecules are present in macrophage lysosomes and phagolysosomes that function in the phagocytic processing of Listeria monocytogenes for presentation to T cells. J Cell Biol 119:531-542, 1992.
38. Rogers HW, Tripp CS, Schrieber RD, Unanue ER. Endogenous IL-1 is required for neutrophil recruitment and macrophage activation during murine listeriosis. J Immunol 153:2093-2101, 1994.